Menu
Currency
GWAS Study

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.

Aulchenko YS, Ripatti S, Lindqvist I et al.

19060911 PubMed ID
GWAS Study Type
22562 Participants
39 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AY
Aulchenko YS
RS
Ripatti S
LI
Lindqvist I
BD
Boomsma D
HI
Heid IM
PP
Pramstaller PP
PB
Penninx BW
JA
Janssens AC
WJ
Wilson JF
ST
Spector T
MN
Martin NG
PN
Pedersen NL
KK
Kyvik KO
KJ
Kaprio J
HA
Hofman A
FN
Freimer NB
JM
Jarvelin MR
GU
Gyllensten U
CH
Campbell H
RI
Rudan I
JA
Johansson A
MF
Marroni F
HC
Hayward C
VV
Vitart V
JI
Jonasson I
PC
Pattaro C
WA
Wright A
HN
Hastie N
PI
Pichler I
HA
Hicks AA
FM
Falchi M
WG
Willemsen G
HJ
Hottenga JJ
DG
de Geus EJ
MG
Montgomery GW
WJ
Whitfield J
MP
Magnusson P
SJ
Saharinen J
PM
Perola M
SK
Silander K
IA
Isaacs A
SE
Sijbrands EJ
UA
Uitterlinden AG
WJ
Witteman JC
OB
Oostra BA
EP
Elliott P
RA
Ruokonen A
SC
Sabatti C
GC
Gieger C
MT
Meitinger T
KF
Kronenberg F
DA
Döring A
WH
Wichmann HE
SJ
Smit JH
MM
McCarthy MI
VD
van Duijn CM
PL
Peltonen L
Chapter II

Abstract

Summary of the research findings

Recent genome-wide association (GWA) studies of lipids have been conducted in samples ascertained for other phenotypes, particularly diabetes. Here we report the first GWA analysis of loci affecting total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides sampled randomly from 16 population-based cohorts and genotyped using mainly the Illumina HumanHap300-Duo platform. Our study included a total of 17,797-22,562 persons, aged 18-104 years and from geographic regions spanning from the Nordic countries to Southern Europe. We established 22 loci associated with serum lipid levels at a genome-wide significance level (P < 5 x 10(-8)), including 16 loci that were identified by previous GWA studies. The six newly identified loci in our cohort samples are ABCG5 (TC, P = 1.5 x 10(-11); LDL, P = 2.6 x 10(-10)), TMEM57 (TC, P = 5.4 x 10(-10)), CTCF-PRMT8 region (HDL, P = 8.3 x 10(-16)), DNAH11 (LDL, P = 6.1 x 10(-9)), FADS3-FADS2 (TC, P = 1.5 x 10(-10); LDL, P = 4.4 x 10(-13)) and MADD-FOLH1 region (HDL, P = 6 x 10(-11)). For three loci, effect sizes differed significantly by sex. Genetic risk scores based on lipid loci explain up to 4.8% of variation in lipids and were also associated with increased intima media thickness (P = 0.001) and coronary heart disease incidence (P = 0.04). The genetic risk score improves the screening of high-risk groups of dyslipidemia over classical risk factors.

21,848 European ancestry individuals, 714 Orcadian individuals

Chapter III

Study Statistics

Key metrics and study information

22562
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Finland, Sweden, Australia, Italy, Netherlands, Germany, U.K., Croatia, Norway, Denmark
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.